Skip to main content
Equibles
PGAC logo

PGAC · PANTAGES CAPITAL ACQUISITION Corp

Track PGAC — free

Use PGAC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$10.73 +0.02 (+0.19%) At close · Sep 8
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern. ... As a result, management has determined that such additional condition also raises substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited financial statements are issued.”
View the 10-Q filed Aug 14, 2026
Market Cap
$55.01M
Shares
5.14M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$10.71 Open$10.75 Day$10.71–10.76 52W close$10.23–10.75 Avg vol 30d7K Short int44K · 0.9% float · 214.9d Short vol60% DataJan 2025–Sep 2026 Filing10-Q · Aug 14

Up next

Latest filing: 10-Q
filed Aug 14, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
$2.04M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
27.0
Trailing earnings · reciprocal yield 3.7%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$352
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+4.7%
Trailing year
Short interest
0.9%
Latest settlement · 214.9 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Strong Buy Momentum Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very Low
Market backdrop VIX 15.7 · calm Equity put/call 0.48
Technical
price trend
Strong Buy
50 / 200-day cross No cross
Price vs 200-day avg +3%
above
Price vs 50-day avg +1%
above
RSI (14) 60
neutral
MACD trend Positive
52-week position 92%
near high
Momentum
relative strength
Strong
1-month return +2%
trailing
6-month return +3%
trailing
YTD return +3%
this year
Relative strength −12%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $11 › 200d $10 — 50d above 200d
Institutional flow Distributing
-18% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.87% of float · ▼ -2.5% MoM · 214.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
28 holders — mid 1-yr range
Squeeze score 55
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very Low
Volatility 3%
annualized · 1-yr
Max drawdown −1%
past year
ATR 0.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Buy
0 · 2 · 4
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+3% Bullish
Price vs 50-day avg
+1% Bullish
RSI (14)
60 Neutral
MACD trend
Positive Bullish
52-week position
92% Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $11 › 200d $10 — 50d above 200d
Institutional flow Distributing
-18% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.87% of float · ▼ -2.5% MoM · 214.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
28 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $10 Now $11 · 92% Range high $11
vs 200-day avg +3% vs 50-day avg +1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Shell Companies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PGAC
PANTAGES CAPITAL ACQUISITION Corp
this stock
$55.01M +3.4% — — 0.9%
CLUS
Cluster Group Holdings Ltd Co
 $8.00B — — — —
CCXI
Churchill Capital Corp XI
 $785.93M — — — 6.0%
DMII
Drugs Made In America Acquisition II Corp.
 $647.51M +2.7% — — 0.2%
EVAC
EQV Ventures Acquisition Corp. II
 $602.01M +2.7% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
28
% held
184.3%
Net QoQ
-5.2M sh
Top holder
Linden Advisors LP
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
44.5K
Days to cover
214.9d
Change
-1.1K sh
View
Short Volume
Short vol %
60%
As of
Sep 8, 2026
Short Total
View
Fails to Deliver
FTD shares
187
Value
$2.0K
As of
Jul 31, 2026
View
Off-Exchange
Off-exchange %
5.9%
Week of
Jul 27, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$2.5M
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 4, 2026
This year
10
View

Performance

5D 20D 120D MTD YTD
PGAC -0.1% +1.6% +3.5% +0.2% +3.4%
SPY +0.1% -0.4% +15.1% +0.4% +12.9%
vs SPY -0.2% +2.0% -11.6% -0.2% -9.6%
Key facts CIK 2030829 CUSIP G8089R100 13F (30d) 13 filings 13 filers